SCHEMBL11176392

SCHEMBL11176392

Brc1ccc(-c2nc(-c3ccccc3)c(-c3ccccc3)[nH]2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 11/20 1.00
MAPK12 P53778 11/20 1.00
MAPK11 Q15759 11/20 1.00
MAPK14 Q16539 11/20 1.00
GCGR P47871 7/20 1.00
TP53 P04637 3/20 0.85
MAPT P10636 3/20 0.85
RAF1 P04049 4/20 0.69
MAPK9 P45984 1/20 0.68
NOX1 Q9Y5S8 1/20 0.65
BRAF P15056 1/20 0.61
ALOX5 P09917 1/20 0.61
KDM4E B2RXH2 1/20 0.60
ALDH1A1 P00352 1/20 0.60
GLA P06280 1/20 0.60
GAA P10253 1/20 0.60
HPGD P15428 1/20 0.60
KMT2A Q03164 1/20 0.60
THRB P10828 1/20 0.59
PTPN1 P18031 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28158811 0.93 MAPK13 (0.86) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL2650068 0.92 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL12561692 0.92 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL14045570 0.92 MAPK13 (0.85) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL6469543 0.92 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL5074753 0.91 MAPK13 (0.83) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL16667652 0.89 MAPK13 (0.83) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL104130 0.89 MAPK13 (0.82) MAPK13MAPK12MAPK11MAPK14GCGR
Benzene SCHEMBL28852698 0.89 MAPK13 (0.82) MAPK13MAPK12MAPK11MAPK14GCGR
SCHEMBL12601196 0.89 MAPK13 (0.78) MAPK13MAPK12MAPK11MAPK14GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11845835-B2 Polymer compound having lophine structure THE UNIVERSITY OF TOKYO (JP) 2023-12-19 US disclosed
US-20210238364-A1 Polymer Compound Having Lophine Structure THE UNIVERSITY OF TOKYO (JP) 2021-08-05 US disclosed
US-20210238364-A1 Polymer Compound Having Lophine Structure THE UNIVERSITY OF TOKYO (JP) 2021-08-05 US disclosed
WO-2019221051-A1 POLYMER COMPOUND HAVING LOPHINE STRUCTURE 国立大学法人 東京大学 (JP) 2019-11-21 WO disclosed
CN-102331684-A Photosensitive element, method for forming resist pattern, method for manufacturing printed wiring board, and printed wiring board HITACHI CHEMICAL CO LTD 2012-01-25 CN disclosed
EP-0082111-A2 Process for the preparation of imidazoles CIBA-GEIGY AG (CH) 1983-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238364-A1 Polymer Compound Having Lophine Structure TST, LTC4S, SSB MAPK13 3368/4885MAPK12 3618/4885MAPK11 2920/4885
US-11845835-B2 Polymer compound having lophine structure TST, LTC4S, SSB MAPK13 3368/4885MAPK12 3618/4885MAPK11 2920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.